APA

Martin-Romano P., Baraibar I., Espinós J., Legaspi J., López-Picazo J. M., Aramendía J. M., Fernández O. A. & Santisteban M. (20190619). Combination of pegylated liposomal doxorubicin plus gemcitabine in heavily pretreated metastatic breast cancer patients: Long-term results from a single institution experience. : The breast journal.

Chicago

Martin-Romano Patricia, Baraibar Iosune, Espinós Jaime, Legaspi Jairo, López-Picazo Jose M, Aramendía Jose Manuel, Fernández Oscar A and Santisteban Marta. 20190619. Combination of pegylated liposomal doxorubicin plus gemcitabine in heavily pretreated metastatic breast cancer patients: Long-term results from a single institution experience. : The breast journal.

Harvard

Martin-Romano P., Baraibar I., Espinós J., Legaspi J., López-Picazo J. M., Aramendía J. M., Fernández O. A. and Santisteban M. (20190619). Combination of pegylated liposomal doxorubicin plus gemcitabine in heavily pretreated metastatic breast cancer patients: Long-term results from a single institution experience. : The breast journal.

MLA

Martin-Romano Patricia, Baraibar Iosune, Espinós Jaime, Legaspi Jairo, López-Picazo Jose M, Aramendía Jose Manuel, Fernández Oscar A and Santisteban Marta. Combination of pegylated liposomal doxorubicin plus gemcitabine in heavily pretreated metastatic breast cancer patients: Long-term results from a single institution experience. : The breast journal. 20190619.